Not applicableUnknownNCT05626101
What this trial is testing
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
Who this might be right for
Non-muscle-invasive Bladder Cancer
Al-Azhar University 280